SCS
TRIL

Syquant Capital SAS’s Trillium Therapeutics Inc. TRIL Stock Holding History

Syquant Capital SAS’s Portfolio TRIL Stock Details TRIL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$878K – 57
2021
Q3 		$878K Buy
+50,000
New +$878K 0.54% 24